The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy

被引:61
|
作者
Kidoya, H. [1 ]
Kunii, N. [2 ,3 ]
Naito, H. [1 ]
Muramatsu, F. [1 ]
Okamoto, Y. [2 ]
Nakayama, T. [3 ]
Takakura, N. [1 ]
机构
[1] Osaka Univ, Res Inst Microbial Dis, Dept Signal Transduct, Suita, Osaka 5650871, Japan
[2] Chiba Univ, Grad Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Chiba, Japan
[3] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan
基金
日本学术振兴会;
关键词
tumor angiogenesis; immune therapy; vascular normalization; vascular maturation; apelin/APJ; KILLER T-CELLS; V-ALPHA-14 NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; IN-VIVO; ENDOTHELIAL-CELLS; ANGIOGENIC FACTOR; BLOOD-VESSELS; APJ RECEPTOR; CANCER; ACTIVATION;
D O I
10.1038/onc.2011.489
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immature and unstable tumor vasculature provides an aberrant tumor microenvironment and leads to resistance of tumors to conventional therapy. Hence, normalization of tumor vessels has been reported to improve the effect of immuno-, chemo- and radiation therapy. However, the humoral factors, which can effectively induce maturation of tumor vasculature, have not been elucidated. In this study, we found that the novel peptide apelin and its receptor APJ can induce the morphological and functional maturation of blood vessels in tumors. This apelin-induced tumor vascular maturation enhances the efficacy of cancer dendritic cell-based immunotherapy and significantly suppresses tumor growth by promoting the infiltration of invariant natural killer T cells into the central region of the tumor and thereby robustly inducing apoptosis of tumor cells. Additionally, we showed APJ expression to be enhanced in the tumor endothelium in comparison with normal-state endothelial cells. These findings provide a new target for tumor vascular-specific maturation, which is expected to improve the efficacy of conventional cancer therapies. Oncogene (2012) 31, 3254-3264; doi:10.1038/onc.2011.489; published online 31 October 2011
引用
收藏
页码:3254 / 3264
页数:11
相关论文
共 50 条
  • [31] Combination therapy using imatinib and vatalanib improves the therapeutic efficiency of paclitaxel towards a mouse melanoma tumor
    Klosowska-Wardega, Agnieszka
    Hasumi, Yoko
    Ahgren, Aive
    Heldin, Carl-Henrik
    Hellberg, Carina
    MELANOMA RESEARCH, 2011, 21 (01) : 57 - 65
  • [32] Strategies for the Construction of Mouse Models With Humanized Immune System and Evaluation of Tumor Immune Checkpoint Inhibitor Therapy
    Guo, Wenwen
    Zhang, Caiqin
    Qiao, Tianyun
    Zhao, Jumei
    Shi, Changhong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] The immune system is pivotal in mediating the anti-tumor effects of radiation therapy
    Gerber, Scott
    Sedlacek, Abigail
    Lord, Edith
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [34] ON A MATHEMATICAL MODEL OF TUMOR-IMMUNE SYSTEM INTERACTIONS WITH AN ONCOLYTIC VIRUS THERAPY
    Jang, Sophia R-J
    Wei, Hsiu-Chuan
    DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B, 2022, 27 (06): : 3261 - 3295
  • [35] Bistability in a model of tumor-immune system interactions with an oncolytic viral therapy
    Vithanage, G. V. R. K.
    Wei, Hsiu-Chuan
    Jang, Sophia R-J
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2022, 19 (02) : 1559 - 1587
  • [36] ONCOLYTIC ADENOVIRUS THERAPY OF MALIGNANT GLIOMA IN IMMUNE COMPETENT MICE INDUCES ANTI-VIRAL AND ANTI-TUMOR IMMUNE RESPONSES
    Kleijn, A.
    Kloezeman, J. J.
    Treffers-Westerlaken, E. J.
    Leenstra, S.
    Dirven, C. M. F.
    Debets, R.
    Lamfers, M. M. L.
    NEURO-ONCOLOGY, 2012, 14 : 23 - 23
  • [37] Tumor-targeted interleukin-12 and Entinostat combination therapy improves cancer survival by reprogramming the tumor immune cell landscape
    Hicks, Kristin C.
    Chariou, Paul L.
    Ozawa, Yohei
    Minnar, Christine M.
    Knudson, Karin M.
    Meyer, Thomas J.
    Bian, Jing
    Cam, Margaret
    Schlom, Jeffrey
    Gameiro, Sofia R.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [38] The impact of the immune system on the safety and efficiency of enzyme replacement therapy in lysosomal storage disorders
    Broomfield, A.
    Jones, S. A.
    Hughes, S. M.
    Bigger, B. W.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2016, 39 (04) : 499 - 512
  • [39] Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor
    Tahtinen, Siri
    Gronberg-Vaha-Koskela, Susanna
    Lumen, Dave
    Merisalo-Soikkeli, Maiju
    Siurala, Mikko
    Airaksinen, Anu J.
    Vaha-Koskela, Markus
    Hemminki, Akseli
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (08) : 915 - 925
  • [40] A Combination of Cowpea Mosaic Virus and Immune Checkpoint Therapy Synergistically Improves Therapeutic Efficacy in Three Tumor Models
    Wang, Chao
    Steinmetz, Nicole F.
    ADVANCED FUNCTIONAL MATERIALS, 2020, 30 (27)